Merck & Co., Inc. (MRK)
97.76
+0.87
(+0.90%)
USD |
NYSE |
Dec 10, 15:55
Merck Total Assets (Quarterly): 129.55B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Biogen, Inc. | 29.21B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Cidara Therapeutics, Inc. | 518.65M |
| Moderna, Inc. | 12.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 77.64B |
| Shareholders Equity (Quarterly) | 51.85B |
| Debt to Equity Ratio | 0.798 |
| Current Ratio | 1.661 |
| Net Debt Paydown Yield | -0.34% |